| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/06/2008 | US20080058270 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080058265 Methods and compositions for activated protein c with reduced anti-coagulant properties |
| 03/06/2008 | US20080058261 Protease susceptibility II |
| 03/06/2008 | US20080058258 Growth Factor |
| 03/06/2008 | US20080058257 Semaphorin protein; gene expression on surface dendritic cells |
| 03/06/2008 | US20080058252 Use of C5A receptor antagonist in the treatment of fibrosis |
| 03/06/2008 | US20080058250 Using mixture of active drug and phosphate binder; active drugs include hypotensive agents, vitamin d, lipids, calcitrol, potassium salts,anemia therapy or alkalization agent |
| 03/06/2008 | US20080058249 Complexes |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability |
| 03/06/2008 | US20080057126 Implant and process for its production |
| 03/06/2008 | US20080057121 Pharmaceutical Composition and Galenic Form Corresponding to Rapid Oral Disintegration and Method for Production of Said Composition |
| 03/06/2008 | US20080057112 preparing a high proportion by % wt. of vitamin emulsion; a emulsion of taste masking flavor of strawberry, blue raspberry, bubble gum, orange or lemon; preparing a polymer base of hydroxypropylmethyl cellulose or carboxymethyl cellulose, mixing, and casting to form a film; non bitter taste |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057108 Functional food and method for preparation thereof |
| 03/06/2008 | US20080057105 Medical devices having nanostructured coating for macromolecule delivery |
| 03/06/2008 | US20080057098 Use of Bcl inhibitors For The Prevention Of Fibroproliferative Reclosure Of Dilated Blood Vessels And Other Iatrogenic Fibroproliferative Disorders |
| 03/06/2008 | US20080057097 Coating comprises one or more cell adhesion polypeptides and a means for temporarily protecting polypeptides from biofouling; coating comprises a bacteriophage, grafted onto polybisphosphonate coating, wherein the bacteriophage displays cell adhesion polypeptides |
| 03/06/2008 | US20080057087 Coating polymer solution onto inert substrate by knife or roller application or spraying and drying, using partially hydrolyzed polyvinyl alcohol, soluble in water; then coating second composition based on polyvinylpyrrolidone, soluble in water, for second layer; quick dissolving; drug delivery |
| 03/06/2008 | US20080057086 Colon-targeted oral formulations of cytidine analogs |
| 03/06/2008 | US20080057081 Influenza Hemagglutinin And Neuraminidase Variants |
| 03/06/2008 | US20080057079 JC Virus Vaccine |
| 03/06/2008 | US20080057078 Chicken Anemia Virus Vaccine from Cell Line |
| 03/06/2008 | US20080057073 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057066 Methods and compositions for targeting relt |
| 03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
| 03/06/2008 | US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer |
| 03/06/2008 | US20080057062 Agent for Inducing senescence and apoptosis of cancer cell |
| 03/06/2008 | US20080057056 Fc Variants with Increased Affinity for FcyRIIC |
| 03/06/2008 | US20080057054 Controlling activity of telencephalin |
| 03/06/2008 | US20080057050 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| 03/06/2008 | US20080057048 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 03/06/2008 | US20080057046 Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 03/06/2008 | US20080057042 Method of providing readily available cellular material derived from cord blood, and a composition thereof |
| 03/06/2008 | US20080057041 Derivation of embryonic stem cells and embryo-derived cells |
| 03/06/2008 | US20080057039 analyzing maternal mitochondrial status, to detect genetic disorders such as Down Syndrome |
| 03/06/2008 | US20080057037 Treatment of neoplasms with viruses |
| 03/06/2008 | US20080057028 Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
| 03/06/2008 | US20080057021 Rinse-off personal care compositions comprising cationic perfume polumeric particles |
| 03/06/2008 | US20080057012 emulsions comprising sunless tanning agents, phosphodiesterase inhibitors, metabolism intensifiers and/or cytokine production activators, used for reducing the appearance of cellulite |
| 03/06/2008 | US20080057007 dentifrices used for removing or inhibiting plaque and tartar, and also for treating and preventing oral and periodontal diseases |
| 03/06/2008 | US20080057005 Hydrogels for the controlled release of bioactive materials |
| 03/06/2008 | US20080057003 Powder inhaler formulations |
| 03/06/2008 | US20080056992 Biological Marker for Inflammation |
| 03/06/2008 | US20080056989 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; tomography; magnetic resonance imaging; benzoindocarbocyanines |
| 03/06/2008 | US20080056987 Inhibitor of Eph receptor kinase; treat angiogenesis, lymphangiogenesis or asculogenesis, disorder of the blood vessels, hyperproliferation of body cells, chronic or acute neurodegenerative disorder; enteral, parenteral and oral administration |
| 03/06/2008 | CA2661873A1 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/06/2008 | CA2661702A1 Method for producing phenoxypyridine derivative |
| 03/06/2008 | CA2661024A1 Small molecule potentiator of hormonal therapy for breast cancer |
| 03/06/2008 | CA2660804A1 Reverse targeting lipid vesicle |
| 03/06/2008 | CA2659339A1 Organic compounds |
| 03/06/2008 | CA2657469A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1894930A1 Thiazole derivative |
| 03/05/2008 | EP1894574A1 Anti-cancer agent comprising protein c inhibitor |
| 03/05/2008 | EP1894568A1 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 03/05/2008 | EP1894566A1 Products containing polyphenol(s) and L-arginine to stimulate nitric oxide production |
| 03/05/2008 | EP1893649A2 Method for the potentiation of opioid analgesics effects on pain |
| 03/05/2008 | EP1564236B1 Polyalkylen glycol derivative |
| 03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1144609B1 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | CN201030063Y Antiperspirant plaster |
| 03/05/2008 | CN101137364A Compositions comprising an epothilone and production methods |
| 03/05/2008 | CN101137344A Hair cosmetic |
| 03/05/2008 | CN101134723A Gallic acid and divalent metal ionic compound and preparation method and application thereof |
| 03/05/2008 | CN101134088A Essential oil for recuperating human body and reliving aching pain and uses thereof |
| 03/05/2008 | CN101134067A Method of producing traditional Chinese medicine for treating hepatopathy and tendons disease |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
| 03/05/2008 | CN100372567C Thrombin derived peptides for promoting cardiac tissue repair |
| 03/05/2008 | CN100372557C Oral liquid capable of raising human body anoxia tolerance and its preparation method |
| 03/05/2008 | CN100372547C Use of compound red-rooted salvia drop pills in preparation of mass cell degranulation prohibiting drug |
| 03/05/2008 | CN100372542C Use of algin oligocauharide as prebiotics |
| 03/05/2008 | CN100372539C Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 03/05/2008 | CN100372536C Tablets quickly disintegrated in oral cavity |
| 03/05/2008 | CN100372533C Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 03/05/2008 | CN100372530C Tegaserod maleate oral preparation. |
| 03/05/2008 | CN100372526C Warm poultice |
| 03/04/2008 | US7340299 Methods of indirectly stimulating the vagus nerve to achieve controlled asystole |
| 03/04/2008 | US7339089 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 03/04/2008 | US7339061 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/04/2008 | US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338953 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338666 Methods for modulating the axonal outgrowth of central nervous system neurons |